Suven Life up 5%; Taro to sell co's anti-lice lotion in US

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Moneycontrol Bureau

Shares of Suven Life Sciences rallied as much as 5 percent intraday on Tuesday after the company granted an exclusive license and right to distribute its Malathion lotion.

This lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.

"Suven Life Sciences today has granted an exclusive license and right to distribute and market its Malathion Lotion USP 0.5 percent w/v with US patent # 8,138,366 and ANDA 091559 in USA, Canada and Mexico to Taro Pharmaceuticals North America, a subsidiary of Taro Pharmaceutical Industries," the company said in its filing.

In consideration for the exclusive license and right to distribute and market Malathion lotion, Taro will pay Suven a royalty and the arrangement is effective until April 2028 unless otherwise terminated.

At 13:23 hours IST, the stock rose 2.12 percent to Rs 74.80 amid high volumes on the BSE.

Posted by Sunil Shankar Matkar